KTN Launches UK Medicines Manufacturing Landscape Portal
The portal is an interactive tool that pulls together the innovation landscape, company base, and manufacturing sites for the entire medicines sector in the UK.
The Knowledge Transfer Network (KTN), the United Kingdom’s innovation network, announced the launch of a new web portal that outlines the UK’s strengths and capabilities in medicines manufacturing.
KTN’s Medicines Manufacturing Landscape portal is an interactive tool that pulls together the innovation landscape, company base, and manufacturing sites for the entire medicines sector in the UK. The platform was developed by KTN on behalf of the Medicines Manufacturing Industry Partnership (MMIP) to address confusion about medicines manufacturing activities in the UK.
The MMIP was jointly established by the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) and includes partners such as Actavis (Allergan plc), AstraZeneca, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, KTN, ReNeuron, and Pfizer. This partnership was formed to strengthen collaboration between the industry and the government in making the UK an attractive and innovation-driven country for medicines manufacturing.
Source: KTN
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
